Tool for Converting ADHD Rating Scales Scores Based on Individual Participant Data from 53 Randomized Controlled Trials of ADHD Medications.

Saved in:
Bibliographic Details
Title: Tool for Converting ADHD Rating Scales Scores Based on Individual Participant Data from 53 Randomized Controlled Trials of ADHD Medications.
Authors: Christogiannis C; Developmental EPI (Evidence synthesis, Prediction, Implementation) Lab, Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK., Garcia-Argibay M; Developmental EPI (Evidence synthesis, Prediction, Implementation) Lab, Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.; Hampshire and Isle of Wight Healthcare NHS Foundation Trust, Southampton, UK.; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Tomlinson A; Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.; Oxford Precision Psychiatry Lab, National Institute for Health and Care Research Oxford Health Biomedical Research Centre, Oxford, UK., Roy S; School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.; Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK., Farhat LC; Department of Psychiatry, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil., Fusetto Veronesi G; 3i-lab, Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK., Parlatini V; Hampshire and Isle of Wight Healthcare NHS Foundation Trust, Southampton, UK.; School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.; 3i-lab, Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.; Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, University of Southampton, Southampton, UK.; Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.; Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK., Bellato A; School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.; Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.; School of Psychology, University of Nottingham, Semenyih, Malaysia.; South-East Asia Mental Health Consortium (SEAMHC), University of Nottingham, Semenyih, Malaysia., Gosling CJ; Developmental EPI (Evidence synthesis, Prediction, Implementation) Lab, Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.; Laboratoire DysCo, Université Paris Nanterre, Nanterre, France.; Department of Child and Adolescent Psychiatry, Institut Robert Debré du Cerveau de l'enfant Robert Debré Hospital, APHP, Paris, France., Mavridis D; Department of Primary Education, University of Ioannina, Ioannina, Greece., Efthimiou O; Developmental EPI (Evidence synthesis, Prediction, Implementation) Lab, Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.; Institute of Primary Health Care (BIHAM), University of Bern, Switzerland.; Institute of Social and Preventive Medicine (ISPM), University of Bern, Switzerland., Ostinelli EG; Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.; Oxford Precision Psychiatry Lab, National Institute for Health and Care Research Oxford Health Biomedical Research Centre, Oxford, UK.; NIHR Oxford Health Clinical Research Facility, Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK., Cipriani A; Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.; Oxford Precision Psychiatry Lab, National Institute for Health and Care Research Oxford Health Biomedical Research Centre, Oxford, UK.; NIHR Oxford Health Clinical Research Facility, Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK., Cortese S; Developmental EPI (Evidence synthesis, Prediction, Implementation) Lab, Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.; Hampshire and Isle of Wight Healthcare NHS Foundation Trust, Southampton, UK.; Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, University of Southampton, Southampton, UK.; Hassenfeld Children's Hospital at NYU Langone, New York University Child Study Center, New York City, New York, USA.; DiMePRe-J Department of Precision and Regenerative Medicine, Jonic Area, University of Bari 'Aldo Moro,' Bari, Italy.
Source: Journal of child and adolescent psychopharmacology [J Child Adolesc Psychopharmacol] 2026 Jun 18, pp. 10445463261461541. Date of Electronic Publication: 2026 Jun 18.
Publication Type: Journal Article
Journal Info: Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 9105358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8992 (Electronic) Linking ISSN: 10445463 NLM ISO Abbreviation: J Child Adolesc Psychopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1557-8992
DOI:10.1177/10445463261461541